Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breakthrough Cancer Pain”

74 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 74 results

Large-scale testing (Phase 3)Study completedNCT00293020
What this trial is testing

Study of the Safety of BEMA™ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid Therapy

Who this might be right for
PainCancer
BioDelivery Sciences International 244
Not applicableNot Yet RecruitingNCT06790719
What this trial is testing

Paediatric Breakthrough Pain Assessment

Who this might be right for
Breakthrough PainPalliative MedicineOncology Pain+2 more
University of Southampton 210
Not applicableUnknownNCT02069067
What this trial is testing

Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated

Who this might be right for
Advanced Cancer
National Cancer Institute, Naples 500
Large-scale testing (Phase 3)Study completedNCT00459277
What this trial is testing

Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids

Who this might be right for
Cancer Pain
Archimedes Development Ltd 73
Post-approval studies (Phase 4)Ended earlyNCT01812759
What this trial is testing

Fentanyl for Breakthrough Pain in the Emergency Department

Who this might be right for
Pain
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00833040
What this trial is testing

The Evaluation of the Safety, Tolerability, and Efficacy of ARX-F02 (Sufentanil NanoTab) Compared to Placebo in the Treatment of Cancer Breakthrough Pain

Who this might be right for
CancerPain
Talphera, Inc 34
Not applicableLooking for participantsNCT06308328
What this trial is testing

A Real-world Observational Study of a Mucosal Contouring Method for Radiation-induced Oropharyngeal Mucositis

Who this might be right for
Radiation-induced Oropharyngeal MucositisSwallowing-induced Breakthrough Pain
Nanfang Hospital, Southern Medical University 718
Large-scale testing (Phase 3)WithdrawnNCT01980498
What this trial is testing

PEctin Rapid Fentanyl Efficacy Clinical Trial For pAin at Swallowing Undergoing radioTherapy

Who this might be right for
Predictable BTP at Swallowing in in Head/Neck Cancer Patients Undergoing Radiotherapy Already Receiving Opioid Therapy for Background Pain
L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.
Post-approval studies (Phase 4)Study completedNCT00576173
What this trial is testing

An Open Label Study to Evaluate Safety, Tolerability and Clinical Utility of ULTRACET® (37.5mg Tramadol Hydrochloride/325mg Acetaminophen) for the Treatment of Breakthrough Pain in Cancer Patients

Who this might be right for
Pain
Johnson & Johnson Taiwan Ltd 60
Large-scale testing (Phase 3)Ended earlyNCT00125801
What this trial is testing

The Pain Pen for Breakthrough Cancer Pain

Who this might be right for
NeoplasmsPain
Erasmus Medical Center 50
Large-scale testing (Phase 3)Study completedNCT00263575
What this trial is testing

Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients

Who this might be right for
PainCancer
Kyowa Kirin Co., Ltd. 139
Testing effectiveness (Phase 2)Ended earlyNCT00351637
What this trial is testing

Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients

Who this might be right for
CancerPain
Alberta Health services 60
Large-scale testing (Phase 3)UnknownNCT00822614
What this trial is testing

Safety of Fentanyl TAIFUN Treatment

Who this might be right for
Breakthrough Cancer Pain
Akela Pharma, Inc. 500
Large-scale testing (Phase 3)Study completedNCT00696137
What this trial is testing

Long-term Extension Study of BEMA™ Fentanyl

Who this might be right for
Respiratory Depression
BioDelivery Sciences International 5
Testing effectiveness (Phase 2)Study completedNCT00020618
What this trial is testing

Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain

Who this might be right for
PainUnspecified Adult Solid Tumor, Protocol Specific
Dana-Farber Cancer Institute
Large-scale testing (Phase 3)Study completedNCT00293033
What this trial is testing

Study of BEMA™ Fentanyl in the Treatment of Breakthrough Pain in Cancer Subjects

Who this might be right for
PainCancer
BioDelivery Sciences International 152
Large-scale testing (Phase 3)Study completedNCT00236145
What this trial is testing

Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough Pain

Who this might be right for
Breakthrough Pain
Cephalon
Not applicableStudy completedNCT01946555
What this trial is testing

Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain

Who this might be right for
TumorCancer PainBreakthrough Cancer Pain+1 more
Mario Negri Institute for Pharmacological Research 150
Not applicableStudy completedNCT02840500
What this trial is testing

Quality of Life Study in Patients With Cancer Breakthrough Pain Treated in Palliative Care Units

Who this might be right for
Breakthrough Pain
Angelini Farmacéutica 101
Not applicableStudy completedNCT00994760
What this trial is testing

Efficacy and Tolerability of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients Older Than 18 Years

Who this might be right for
Breakthrough PainCancer
Takeda 131
Load More Results